These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 17117054)

  • 41. Elevated hepatocyte growth factor levels at the beginning of high-flux hemodialysis are due to heparin administration.
    Christidou F; Bamichas G; Galaktidou G; Fragidis S; Gionanlis L; Frangia T; Bischiniotis T; Sombolos K
    Ren Fail; 2008; 30(9):861-4. PubMed ID: 18925524
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increasing dialysate flow rate increases dialyzer urea clearance and dialysis efficiency: an in vivo study.
    Azar AT
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1023-9. PubMed ID: 19861865
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low-dose heparinization can be used with DEAE-cellulose hemodialysis membranes.
    Ward RA; Schmidt B; Gurland HJ
    ASAIO Trans; 1990; 36(3):M321-4. PubMed ID: 2252689
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dialyzer reuse--part II: advantages and disadvantages.
    Twardowski ZJ
    Semin Dial; 2006; 19(3):217-26. PubMed ID: 16689973
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Experience with the multiple use of dialyzers].
    Strokov AG; Poz IaL; Baeva LB; Levitskiĭ ER; Annenkov AE; Rud'ko IA; Kubatiev AA
    Ter Arkh; 1994; 66(6):60-5. PubMed ID: 7940372
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Kinetics of anticoagulation in hemodialysis. Sequential study of single, intermittent and continuous heparinization].
    Ghezzi PM; Di Siena F; Palanca R; Dutto A; Cento G
    Minerva Med; 1980 Oct; 71(41):2987-91. PubMed ID: 7454084
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dialyzer reuse-Part I: Historical perspective.
    Twardowski ZJ
    Semin Dial; 2006; 19(1):41-53. PubMed ID: 16423181
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of dialyzer membrane flux in bio-incompatibility.
    Davenport A
    Hemodial Int; 2008 Oct; 12 Suppl 2():S29-33. PubMed ID: 18837767
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pulse push/pull hemodialysis in a canine renal failure model.
    Lee K; Min BG; Mun CH; Lee SR; Won YS
    Blood Purif; 2008; 26(6):491-7. PubMed ID: 18841004
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Reprocessing of capillary dialyzers].
    Stetsiuk EA; Iarmolinskiĭ IS; Ponomareva VIu; Makhlin NV
    Urol Nefrol (Mosk); 1989; (1):55-9. PubMed ID: 2718285
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of three different heparin regimes on heparin concentrations in plasma and fibrin formation in dialyzers.
    Gunnarsson B; Asaba H; Dawidson S; Wilhelmsson S; Bergström J
    Clin Nephrol; 1981 Mar; 15(3):135-42. PubMed ID: 7273488
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Factors which influence phosphorus removal in hemodialysis].
    Gallar P; Ortiz M; Ortega O; Rodríguez I; Seijas V; Carreño A; Oliet A; Vigil A
    Nefrologia; 2007; 27(1):46-52. PubMed ID: 17402879
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low-molecular-weight heparin for routine hemodialysis.
    Davenport A
    Hemodial Int; 2008 Oct; 12 Suppl 2():S34-7. PubMed ID: 18837768
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
    Yokoyama H; Kawaguchi T; Wada T; Takahashi Y; Higashi T; Yamazaki S; Fukuhara S; Akiba T; Akizawa T; Asano Y; Kurokawa K; Saito A;
    Nephron Clin Pract; 2008; 109(2):c100-8. PubMed ID: 18596379
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The technology of dialyzer reuse.
    Schoenfeld PY
    Semin Nephrol; 1997 Jul; 17(4):321-30. PubMed ID: 9241717
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Large surface area dialysis; innovations and patient management.
    Smith LJ
    Nurs Clin North Am; 1975 Sep; 10(3):481-90. PubMed ID: 1041630
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Computational evaluation of dialysis fluid flow in dialyzers with variously designed jackets.
    Yamamoto K; Matsuda M; Hirano A; Takizawa N; Iwashima S; Yakushiji T; Fukuda M; Miyasaka T; Sakai K
    Artif Organs; 2009 Jun; 33(6):481-6. PubMed ID: 19473145
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does monitoring of pre-/post-dialyzer pressure difference improve efficiency in intermittent hemodialysis?
    Gabutti L; Colucci G; Martella A; Schönholzer C; Marone C
    Blood Purif; 2003; 21(4-5):294-300. PubMed ID: 12944729
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Use of activated coagulation time for evaluation of the degree of heparinization and calculation of heparin pharmacokinetic parameters during hemodialysis].
    Khodas MIa; Piatnitskaia GKh; Lanskaia IM; Maksimenko VA; Savina ME
    Urol Nefrol (Mosk); 1988; (3):42-8. PubMed ID: 3218006
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmacodynamics of unfractionated heparin during and after a hemodialysis session.
    Brunet P; Simon N; Opris A; Faure V; Lorec-Penet AM; Portugal H; Dussol B; Berland Y
    Am J Kidney Dis; 2008 May; 51(5):789-95. PubMed ID: 18436089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.